A salt substitute with less sodium reduced rates of stroke and heart attack in rural China, according to a recent trial.
Harmful side effects from a common chemotherapy drug could be prevented in patients with a specific mutation by targeting retinoic acid receptors, according to a recent study.
Northwestern Medicine is part of the research team on a $185 million NIH project that will explore the millions of genetic variants that cause disease around the world.
Northwestern Medicine scientists have characterized several variants of the gene GRIK2 that cause nonsyndromic neurodevelopmental disorder.
Circulating tumor cells use the surface protein ICAM1 to strengthen stem cell programs and facilitate formation of tumor cell clusters, which can travel from primary tumors to other organs in the body.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, according to a new study, the first to show the process beginning so early.
An international team of investigators have released the first-ever study to examine total energy expenditure over the course of the human lifespan, shedding light on human development and aging.
Epigenetic aging could serve as a promising biomarker for measuring long-term cardiovascular health and disease risk, according to a recent Northwestern Medicine study.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has been awarded a five-year, $9.2 million grant renewal from the National Cancer Institute to continue a Specialized Program of Research Excellence (SPORE) in prostate cancer.
Women with early, nonviable pregnancies of unknown location who were given an active management strategy had more successful pregnancy resolutions than those given an expectant management strategy, according to a randomized clinical trial published in JAMA.